BioLife Solutions, Inc. (BLFS)
USD 24.98
(-7.03%)
USD 24.98
(-7.03%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 117.57 Million USD | 5.73% |
| 2022 | 93.73 Million USD | 37.61% |
| 2021 | 68.11 Million USD | 121.34% |
| 2020 | 30.77 Million USD | 69.33% |
| 2019 | 18.17 Million USD | 84.25% |
| 2018 | 9.86 Million USD | 26.42% |
| 2017 | 7.8 Million USD | -18.98% |
| 2016 | 9.63 Million USD | 9.04% |
| 2015 | 8.83 Million USD | 43.11% |
| 2014 | 6.17 Million USD | 52.44% |
| 2013 | 4.04 Million USD | 25.15% |
| 2012 | 3.23 Million USD | 23.8% |
| 2011 | 2.61 Million USD | 16.1% |
| 2010 | 2.25 Million USD | -21.36% |
| 2009 | 2.86 Million USD | -5.09% |
| 2008 | 3.01 Million USD | -6.43% |
| 2007 | 3.22 Million USD | 79.09% |
| 2006 | 1.79 Million USD | 81.37% |
| 2005 | 992.17 Thousand USD | -11.5% |
| 2004 | 1.12 Million USD | -49.1% |
| 2003 | 2.2 Million USD | 49.95% |
| 2002 | 1.46 Million USD | -70.36% |
| 2001 | 4.95 Million USD | 30.74% |
| 2000 | 3.79 Million USD | 69.17% |
| 1999 | 2.24 Million USD | -4.12% |
| 1998 | 2.33 Million USD | -29.39% |
| 1997 | 3.3 Million USD | 0.0% |
| 1996 | - USD | -100.0% |
| 1995 | 9.64 Million USD | 3.7% |
| 1994 | 9.3 Million USD | 16.25% |
| 1993 | 8 Million USD | 233.33% |
| 1992 | 2.4 Million USD | 50.0% |
| 1991 | 1.6 Million USD | 60.0% |
| 1990 | 1 Million USD | 400.0% |
| 1989 | 200 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 21.53 Million USD | -1.68% |
| 2024 Q2 | 16.77 Million USD | 4.51% |
| 2023 Q1 | 26.92 Million USD | 11.33% |
| 2023 FY | 99.1 Million USD | 5.73% |
| 2023 Q2 | 28.01 Million USD | 4.03% |
| 2023 Q4 | 21.9 Million USD | -17.42% |
| 2023 Q3 | 26.52 Million USD | -5.29% |
| 2022 FY | 93.73 Million USD | 37.61% |
| 2022 Q1 | 22.73 Million USD | -2.18% |
| 2022 Q2 | 23.05 Million USD | 1.43% |
| 2022 Q3 | 22.79 Million USD | -1.13% |
| 2022 Q4 | 24.18 Million USD | 6.08% |
| 2021 FY | 68.11 Million USD | 121.34% |
| 2021 Q3 | 19.89 Million USD | 30.73% |
| 2021 Q2 | 15.21 Million USD | 55.72% |
| 2021 Q4 | 23.23 Million USD | 16.83% |
| 2021 Q1 | 9.77 Million USD | 4.46% |
| 2020 Q1 | 7.06 Million USD | 15.04% |
| 2020 Q3 | 7.52 Million USD | 10.18% |
| 2020 Q4 | 9.35 Million USD | 24.36% |
| 2020 FY | 30.77 Million USD | 69.33% |
| 2020 Q2 | 6.82 Million USD | -3.33% |
| 2019 Q4 | 6.13 Million USD | 27.21% |
| 2019 Q1 | 3.42 Million USD | 26.67% |
| 2019 Q2 | 3.78 Million USD | 10.54% |
| 2019 FY | 18.17 Million USD | 84.25% |
| 2019 Q3 | 4.82 Million USD | 27.5% |
| 2018 Q1 | 2.31 Million USD | 12.31% |
| 2018 FY | 9.86 Million USD | 26.42% |
| 2018 Q4 | 2.7 Million USD | 8.48% |
| 2018 Q3 | 2.49 Million USD | 5.75% |
| 2018 Q2 | 2.35 Million USD | 1.95% |
| 2017 Q1 | 1.9 Million USD | -4.57% |
| 2017 Q2 | 1.94 Million USD | 2.12% |
| 2017 FY | 7.8 Million USD | -18.98% |
| 2017 Q4 | 2.05 Million USD | 8.31% |
| 2017 Q3 | 1.9 Million USD | -2.17% |
| 2016 Q3 | 2.35 Million USD | -13.24% |
| 2016 Q2 | 2.71 Million USD | 5.35% |
| 2016 Q1 | 2.57 Million USD | 1.16% |
| 2016 FY | 9.63 Million USD | 9.04% |
| 2016 Q4 | 1.99 Million USD | -15.27% |
| 2015 Q3 | 2.26 Million USD | 14.96% |
| 2015 Q2 | 1.97 Million USD | -3.36% |
| 2015 Q4 | 2.54 Million USD | 12.07% |
| 2015 FY | 8.83 Million USD | 43.11% |
| 2015 Q1 | 2.04 Million USD | 2.03% |
| 2014 FY | 6.17 Million USD | 52.44% |
| 2014 Q4 | 2 Million USD | 36.89% |
| 2014 Q3 | 1.46 Million USD | 2.07% |
| 2014 Q2 | 1.43 Million USD | 12.63% |
| 2014 Q1 | 1.27 Million USD | 5.61% |
| 2013 Q2 | 911.28 Thousand USD | -2.34% |
| 2013 Q3 | 998.95 Thousand USD | 9.62% |
| 2013 Q4 | 1.2 Million USD | 20.61% |
| 2013 FY | 4.04 Million USD | 25.15% |
| 2013 Q1 | 933.15 Thousand USD | -11.9% |
| 2012 Q4 | 1.05 Million USD | 42.33% |
| 2012 Q3 | 744.15 Thousand USD | -2.38% |
| 2012 Q1 | 669.01 Thousand USD | 0.2% |
| 2012 Q2 | 762.29 Thousand USD | 13.94% |
| 2012 FY | 3.23 Million USD | 23.8% |
| 2011 Q4 | 667.65 Thousand USD | 1.97% |
| 2011 Q2 | 593.94 Thousand USD | -14.72% |
| 2011 Q1 | 696.47 Thousand USD | 33.27% |
| 2011 Q3 | 654.77 Thousand USD | 10.24% |
| 2011 FY | 2.61 Million USD | 16.1% |
| 2010 FY | 2.25 Million USD | -21.36% |
| 2010 Q4 | 522.58 Thousand USD | 2.26% |
| 2010 Q3 | 511.04 Thousand USD | -12.66% |
| 2010 Q2 | 585.14 Thousand USD | -7.49% |
| 2010 Q1 | 632.53 Thousand USD | 31.07% |
| 2009 Q1 | 880.23 Thousand USD | -0.83% |
| 2009 Q3 | 550.7 Thousand USD | -42.06% |
| 2009 Q2 | 950.41 Thousand USD | 7.97% |
| 2009 Q4 | 482.6 Thousand USD | -12.37% |
| 2009 FY | 2.86 Million USD | -5.09% |
| 2008 FY | 3.01 Million USD | -6.43% |
| 2008 Q2 | 645.29 Thousand USD | -10.36% |
| 2008 Q4 | 887.56 Thousand USD | 16.39% |
| 2008 Q1 | 719.84 Thousand USD | -6.5% |
| 2008 Q3 | 762.59 Thousand USD | 18.18% |
| 2007 Q3 | 895.48 Thousand USD | 3.42% |
| 2007 Q1 | 691.36 Thousand USD | 24.77% |
| 2007 Q2 | 865.88 Thousand USD | 25.24% |
| 2007 Q4 | 769.92 Thousand USD | -14.02% |
| 2007 FY | 3.22 Million USD | 79.09% |
| 2006 Q3 | 460.38 Thousand USD | -9.74% |
| 2006 Q4 | 554.1 Thousand USD | 20.36% |
| 2006 FY | 1.79 Million USD | 81.37% |
| 2006 Q1 | 274.94 Thousand USD | 6.46% |
| 2006 Q2 | 510.07 Thousand USD | 85.52% |
| 2005 Q1 | 237.14 Thousand USD | 26162.24% |
| 2005 Q2 | 228.68 Thousand USD | -3.57% |
| 2005 Q3 | 268.07 Thousand USD | 17.22% |
| 2005 Q4 | 258.26 Thousand USD | -3.66% |
| 2005 FY | 992.17 Thousand USD | -11.5% |
| 2004 Q2 | 374.98 Thousand USD | -13.46% |
| 2004 FY | 1.12 Million USD | -49.1% |
| 2004 Q4 | 903.00 USD | -99.7% |
| 2004 Q3 | 302.38 Thousand USD | -19.36% |
| 2004 Q1 | 433.32 Thousand USD | 34.89% |
| 2003 Q4 | 321.24 Thousand USD | -55.61% |
| 2003 FY | 2.2 Million USD | 49.95% |
| 2003 Q1 | 558.7 Thousand USD | -7.8% |
| 2003 Q2 | 585.24 Thousand USD | 4.75% |
| 2003 Q3 | 723.74 Thousand USD | 23.67% |
| 2002 FY | 1.46 Million USD | -70.36% |
| 2002 Q1 | 602.85 Thousand USD | -28.08% |
| 2002 Q3 | 348.08 Thousand USD | -13.8% |
| 2002 Q2 | 403.79 Thousand USD | -33.02% |
| 2002 Q4 | 606 Thousand USD | 74.1% |
| 2001 Q1 | 1.3 Million USD | -5.23% |
| 2001 FY | 4.95 Million USD | 30.74% |
| 2001 Q4 | 838.18 Thousand USD | -35.14% |
| 2001 Q3 | 1.29 Million USD | -14.81% |
| 2001 Q2 | 1.51 Million USD | 15.96% |
| 2000 Q1 | 481.09 Thousand USD | -50.91% |
| 2000 Q4 | 1.38 Million USD | 57.88% |
| 2000 Q3 | 874.42 Thousand USD | -17.08% |
| 2000 Q2 | 1.05 Million USD | 119.19% |
| 2000 FY | 3.79 Million USD | 69.17% |
| 1999 Q1 | 399.99 Thousand USD | 68.68% |
| 1999 Q3 | 290 Thousand USD | 0.0% |
| 1999 Q4 | 979.99 Thousand USD | 237.93% |
| 1999 FY | 2.24 Million USD | -4.12% |
| 1999 Q2 | 290 Thousand USD | -27.5% |
| 1998 Q4 | 237.13 Thousand USD | -60.48% |
| 1998 Q1 | 900 Thousand USD | 11.14% |
| 1998 Q2 | 600 Thousand USD | -33.33% |
| 1998 Q3 | 600 Thousand USD | 0.0% |
| 1998 FY | 2.33 Million USD | -29.39% |
| 1997 FY | 3.3 Million USD | 0.0% |
| 1997 Q1 | 900 Thousand USD | 0.0% |
| 1997 Q3 | 700 Thousand USD | -30.0% |
| 1997 Q4 | 809.78 Thousand USD | 15.68% |
| 1997 Q2 | 1 Million USD | 11.11% |
| 1996 Q3 | 900 Thousand USD | -46.88% |
| 1996 Q1 | 1.6 Million USD | -5.88% |
| 1996 Q2 | 1.69 Million USD | 5.89% |
| 1996 FY | - USD | -100.0% |
| 1995 Q3 | 1.6 Million USD | -21.71% |
| 1995 FY | 9.64 Million USD | 3.7% |
| 1995 Q1 | 2.7 Million USD | 0.0% |
| 1995 Q4 | 1.7 Million USD | 6.25% |
| 1995 Q2 | 2.04 Million USD | -24.31% |
| 1994 Q2 | 2.4 Million USD | -4.0% |
| 1994 Q3 | 2.3 Million USD | -4.17% |
| 1994 Q1 | 2.5 Million USD | 4.17% |
| 1994 FY | 9.3 Million USD | 16.25% |
| 1994 Q4 | - USD | -100.0% |
| 1993 FY | 8 Million USD | 233.33% |
| 1993 Q4 | 2.4 Million USD | 20.0% |
| 1993 Q3 | 2 Million USD | -28.57% |
| 1993 Q2 | 2.8 Million USD | 40.0% |
| 1993 Q1 | 2 Million USD | 11.11% |
| 1992 Q2 | -5.1 Million USD | 0.0% |
| 1992 FY | 2.4 Million USD | 50.0% |
| 1992 Q4 | 1.8 Million USD | 12.5% |
| 1992 Q3 | 1.6 Million USD | 131.37% |
| 1992 Q1 | - USD | -100.0% |
| 1991 Q4 | 500 Thousand USD | 0.0% |
| 1991 FY | 1.6 Million USD | 60.0% |
| 1991 Q2 | -2.8 Million USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q3 | - USD | 100.0% |
| 1990 Q3 | 400 Thousand USD | 122.22% |
| 1990 Q4 | - USD | -100.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 FY | 1 Million USD | 400.0% |
| 1990 Q2 | -1.8 Million USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 FY | 200 Thousand USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 100.0% |
| 1989 Q2 | -400 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | -12.762% |
| AngioDynamics, Inc. | 252.41 Million USD | 53.419% |
| AtriCure, Inc. | 327.05 Million USD | 64.05% |
| Avinger, Inc. | 18.63 Million USD | -530.846% |
| Azenta, Inc. | 336.26 Million USD | 65.035% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 93.557% |
| Daxor Corporation | 1.28 Million USD | -9082.009% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | -386.036% |
| Femasys Inc. | 15.2 Million USD | -673.517% |
| GlucoTrack, Inc. | 7.1 Million USD | -1555.082% |
| Harvard Bioscience, Inc. | 58.58 Million USD | -100.708% |
| Hologic, Inc. | 1.34 Billion USD | 91.26% |
| ICU Medical, Inc. | 717.04 Million USD | 83.603% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 96.031% |
| KORU Medical Systems, Inc. | 26.1 Million USD | -350.351% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | -30.154% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 98631.79% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 98631.79% |
| Masimo Corporation | 867 Million USD | 86.439% |
| Microbot Medical Inc. | 9.85 Million USD | -1093.07% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -538.309% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 74.436% |
| Nephros, Inc. | 9.78 Million USD | -1101.727% |
| NovoCure Limited | 613.92 Million USD | 80.848% |
| NEXGEL, Inc. | 4.09 Million USD | -2770.532% |
| NEXGEL, Inc. | 4.09 Million USD | -2770.532% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | -14.998% |
| OraSure Technologies, Inc. | 125.34 Million USD | 6.195% |
| Pro-Dex, Inc. | 7.37 Million USD | -1493.616% |
| Pulse Biosciences, Inc. | 43.57 Million USD | -169.833% |
| Predictive Oncology Inc. | 15.22 Million USD | -672.033% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -1279.67% |
| QuidelOrtho Corporation | 1.35 Billion USD | 91.325% |
| Repligen Corporation | 261.12 Million USD | 54.973% |
| Sanara MedTech Inc. | 61.12 Million USD | -92.348% |
| STAAR Surgical Company | 224.55 Million USD | 47.64% |
| Sharps Technology, Inc. | 10.12 Million USD | -1061.065% |
| Utah Medical Products, Inc. | 13.26 Million USD | -786.638% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 93.446% |
| Jin Medical International Ltd. | 3.91 Million USD | -2901.272% |